Praying for PYC to have favor with the FDA who have only had a handful of CPP-PMO IND before them, and probably the first ocular application of this nature.
Rohan uses the word “white space” this applies to both the science, regulatory and patient market = new frontier to be forged, and potentially usher in a unique leadership role for PYC to play in this new corner of the biotech-pharma industry.
as a side note, I noticed 17c strike price for new options; this is comforting for me as it indicates management internal valuation - am not sure how long the current 60% discount to previous cap raise price will persist - it’s a great deal for beneficiaries.
I do hope to breakeven on this tranche once FDA approves, not that I’ll be selling - but it also provides great motivation as these options for employees can go to being $1 in the moment I believe if all three programs make receive IND, and VP-001 show some efficacy which enhances look through valuation for the pipeline.
- Forums
- ASX - By Stock
- PYC
- The Attractions of PYC's pipeline
The Attractions of PYC's pipeline, page-22
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $606.5M |
Open | High | Low | Value | Volume |
12.5¢ | 13.0¢ | 12.0¢ | $415.6K | 3.255M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 112056 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 127118 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 112056 | 0.125 |
17 | 1109619 | 0.120 |
12 | 1226909 | 0.115 |
10 | 527452 | 0.110 |
11 | 1201829 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 166 | 1 |
0.135 | 806167 | 10 |
0.140 | 803540 | 4 |
0.145 | 450000 | 2 |
0.150 | 845000 | 5 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |